In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Bayern Cruises to Pennsylvania Derby Win
- Untapable Unstoppable in Grade I Cotillion
- Miss Behaviour Romps in Charles Town Oaks
- Game On Dude, Won Three Big 'Caps, Retired
- California Chrome Draws Rail in PA Derby
- Suffolk Open to Any Viable Plans for Racing
- Artemis Agrotera Gets Up to Win Gallant Bloom
- Top Filly Princess of Sylmar Retired
- Thank You Marylou Coasts Clear in Dogwood
- Moreno, Itsmyluckyday Work for Super Saturday